Tirzepatide 15mg

Tirzepatide 15mg

Tirzepatide, a novel research treatment of type 2 diabetes and obesity, represents a significant advancement in pharmacotherapy. It’s a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This dual mechanism of action sets it apart from other antidiabetic drugs.

This product can only be viewed by members.